Sabinsa Wins Supreme Court Ruling
The company has successfully defended its trademarked ForsLean ingredient, which was contested by Creative Compounds LLC’s marketing of an ingredient called “Forsthin.”
Sabinsa Corp. (East Windsor, NJ) has successfully defended its trademarked ForsLean ingredient, which was contested by Creative Compounds LLC’s (Scott City, MO) marketing of an ingredient called “Forsthin.” Both ingredients are Coleus forskohlii extracts.
A district court ruling originally ruled that the two ingredients could not be confused with each other, but in July 2010, the U.S. Court of Appeals ruled against Creative Compounds over copyright infringement.
On January 10, the U.S. Supreme Court denied Creative Compounds’ petition for judicial review, indicating that there was potential for confusion surrounding the two ingredients.
The full language of the Supreme Court’s decision in favor of Sabinsa ForsLean is currently available.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
